Shanghai Haixin Group Co Ltd B (900917) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haixin Group Co Ltd B (900917) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.56 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Shanghai Haixin Group Co Ltd B worth for the company's overall valuation and market capitalisation.
Shanghai Haixin Group Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Shanghai Haixin Group Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Haixin Group Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haixin Group Co Ltd B ranked by their cash flow conversion efficiency. Explore Shanghai Haixin Group Co Ltd B cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Menang Corporation (Malaysia) Bhd
KLSE:1694
|
0.035x |
|
Hsin Ba Ba Corp
TW:9906
|
-0.185x |
|
WiSoL CO.LTD
KQ:122990
|
0.024x |
|
Softronic AB
ST:SOF-B
|
0.055x |
|
Kee Tai Properties Co Ltd
TW:2538
|
-0.013x |
|
Air Busan Co Ltd
KO:298690
|
0.154x |
|
Cnergenz Bhd
KLSE:0246
|
0.031x |
|
Central Proteina Prima Tbk
JK:CPRO
|
0.013x |
Annual Cash Flow Conversion Efficiency for Shanghai Haixin Group Co Ltd B (2015–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haixin Group Co Ltd B from 2015 to 2025. View 900917 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.92 Billion | $117.69 Million | 0.024x | +38.99% |
| 2024-12-31 | $4.50 Billion | $77.52 Million | 0.017x | +298.48% |
| 2023-12-31 | $4.14 Billion | $-35.88 Million | -0.009x | -147.41% |
| 2022-12-31 | $4.02 Billion | $73.56 Million | 0.018x | -64.31% |
| 2021-12-31 | $4.28 Billion | $219.65 Million | 0.051x | +83.35% |
| 2020-12-31 | $4.38 Billion | $122.50 Million | 0.028x | +535.28% |
| 2019-12-31 | $4.05 Billion | $-26.02 Million | -0.006x | -141.97% |
| 2018-12-31 | $3.63 Billion | $55.50 Million | 0.015x | +354.26% |
| 2017-12-31 | $3.95 Billion | $13.31 Million | 0.003x | +173.71% |
| 2016-12-31 | $4.34 Billion | $-19.84 Million | -0.005x | +81.37% |
| 2015-12-31 | $4.80 Billion | $-117.88 Million | -0.025x | -- |
About Shanghai Haixin Group Co Ltd B
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics… Read more